Intermittent fasting: Does a new study show downsides — or not?

Intermittent fasting (IF) is an approach to eating based on timing. The idea is that fasting for long enough allows insulin levels to fall low enough that our body will use fat for fuel. Growing evidence in animals and humans shows that this approach leads to significant weight loss. When combined with a nutritious, plant-based diet and regular physical activity, IF can be part of a healthy weight loss or maintenance plan, as I described in an earlier blog post.

Now, a randomized controlled trial published in JAMA claims that IF has no significant weight loss benefit and a substantial negative effect on muscle mass. News outlets picked up the story and ran headlines like A Potential Downside of Intermittent Fasting and An Unintended Side Effect of Intermittent Fasting.

But what did this study actually look at and find?

In the study, 141 patients were randomly assigned to 12 weeks of either a time-restricted eating plan (TRE) that involved fasting for 16 hours and eating only during an eight-hour window of the day, or a consistent meal timing (CMT) eating plan, with three structured meals a day plus snacks.

Neither group received any nutrition education or behavioral counseling, nor was physical activity recommended. There was no true control group (meaning a group that did not receive any instructions about meal timing).

Interestingly, both groups lost weight. Given the headlines, I had to read and reread the results several times, because they show that the IF group lost a statistically significant amount of weight from beginning to end — which wasn’t true in the CMT group. The researchers reported: “There was a significant decrease in weight in the TRE group (−0.94 kg; 95% CI, −1.68 kg to −0.20 kg; P = .01) and a nonsignificant decrease in weight in the CMT group (−0.68 kg; 95% CI, −1.41 kg to 0.05 kg; P = .07).”

Translated into plain English, the IF group lost more weight than could be due to chance: between half a pound and 4 pounds, or an average of 2 pounds. The structured meals group also lost some weight, although the amounts lost could have been due to chance: between 0.1 and 3 pounds, or an average of 1.5 pounds. The upshot was that there wasn’t a significant difference in weight change between the two groups. And the researchers saw a loss of muscle mass in the IF group that didn’t occur in the CMT group.

Diving deeper into the study

By the way, all of these folks may have been eating fried or fast foods, and sugary sodas and candy — we don’t know. The study doesn’t mention quality of diet or physical activity. This isn’t how IF is supposed to be done! And yet the IF folks still lost between half a pound and 4 pounds.

Importantly, the structured meals group also lost weight. While not significant enough to prove it was due to this intervention, for some participants it was enough to make structured meal weight loss differ little from IF weight loss. But think about it: structured meals are an intervention. After all, some people eat more than three times a day, consuming multiple small meals throughout the day. Telling people to limit their eating to three mealtimes plus snacks may actually be helping some to eat less.

The authors very well could have concluded that IF was indeed successful. They might also call for a follow-up study with a true no-intervention control group, as well as behavioral counseling, guidance on a healthy diet, and recommended activity levels for IF and CMT groups.

Does additional support make a difference?

Prior studies of IF that have provided behavioral counseling, and guidance on nutrition and activity, have definitely shown positive results. For example, in a previous blog post I described a 2020 American Journal of Clinical Nutrition study in which 250 overweight or obese adults followed one of three diets for 12 months:

  • IF on the 5:2 protocol, which means drastically reducing food intake for any two of five days of the week (down to 500 calories for women and 700 calories for men)
  • Mediterranean, which emphasized fruits and vegetables, legumes, nuts, seeds, whole grains, and olive oil with moderate fish, chicken, eggs, and dairy, and with an allowance of one glass of wine per day for women and two per day for men
  • Paleo, which emphasized fruits and vegetables, animal proteins, coconut products, butter, and olive oil, along with some nuts, seeds, and legumes.
  • And this is key: all participants were provided education on behavioral strategies for weight loss, stress management, sleep, and exercise.

Everyone lost weight. The IF group lost more than anyone with an average of 8.8 pounds, Mediterranean next at 6.2 pounds, and Paleo last at 4 pounds. Adherence was better with the Mediterranean diet (57%) and IF (54%) than with the Paleo diet (35%), and better adherence resulted in one to three pounds more weight loss. The Mediterranean and IF groups also saw significant drops in blood pressure, another good result.

What about the loss in muscle mass that occurred in the IF group in the JAMA study? While this needs to be studied further, it’s important to note that other research on IF that included guidance on physical activity did not show any loss of muscle mass.

The bottom line

What’s the takeaway here? A high-quality diet and plenty of physical activity — including resistance training — are critical for our good health, and nothing replaces these recommendations. IF is merely a tool, an approach that can be quite effective for weight loss for some folks. While this one negative study adds to the body of literature on IF, it doesn’t reverse it. We simply need more high-quality studies in order to have a better understanding of how to most effectively incorporate IF into a healthy lifestyle.

The post Intermittent fasting: Does a new study show downsides — or not? appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/2TFgz6J

Keeping your family safe this Thanksgiving

So much is different and hard during this pandemic — including planning for the holidays.

It’s understandable to want to gather with friends and family. We are all so worn out by the COVID-19 pandemic, and need some cheering up. And most of us have friends and family that we haven’t been able to really spend time with — or haven’t seen at all — for months.

But gathering with friends and family can bring real risks during the pandemic, especially with cases rising all over the country. All it takes is one sick person — who may not even realize that they are sick — to infect others and spread the virus even more.

The best thing to do, honestly, is to celebrate the holiday with just the people you live with, and to skip in-person sporting (or other) events, or in-person Black Friday shopping. That’s truly the best way to keep everyone safe. Just hunker down, check in virtually, and make plans for next year, when things will hopefully be much better.

Still planning to gather for Thanksgiving?

While experts advise skipping gatherings this Thanksgiving, here are some recommendations to help limit risks for people who plan to celebrate the holiday with others.

Plans to make beforehand

  • Travel safely if you are traveling. The safest way is by car with just the people you live with, but if that requires an overnight stay somewhere, a direct flight is likely safer. If you do fly, look for flights that space people apart, wear a mask, and bring hand sanitizer and wipes.
  • Keep the numbers low. This is just not the year for a big family gathering.
  • Keep the party short. This is not the year for a long family gathering either.
  • Agree on “no symptoms” and “no exposure.” Make sure that everyone understands that anyone who has any symptoms of COVID-19, or has been exposed to someone with the virus, cannot come. That needs to be non-negotiable.
  • Agree to socialize outside if possible. If you have to be inside, do everything you can to improve ventilation, like opening windows (but understand that this is not as safe as being outside).

Seating and food

  • Arrange seating so that there is at least six feet between family members who don’t live together.
  • Be mindful of risks as you plan the meal:
    • Ideally, everyone should bring their own food and not share.
    • If some people will be cooking, ask them to wear gloves and masks. And limit the people involved in preparing shared food.
    • No buffets this year. Think pre-served plates of food that people can grab and bring to their seat.
    • If you are serving food, have one person wearing a mask and gloves do all the serving.
    • Try to use single servings of condiments (like packets of salt and pepper) so that people are not all touching the same container.
  • Use disposable plates, cutlery, and cooking ware, when possible.
  • Use touchless garbage cans or pails.

Masks, physical contact, and sanitizing hands and surfaces

  • Wear masks when you aren’t eating and when you cannot be six feet apart. I know this feels weird and hard at a family gathering, but it’s crucial.
  • No hugs or other physical contact between people who don’t live together. Even elbow bumps are not a good idea. Not this year.
  • Everyone should wash their hands often. Have hand sanitizer available.
  • Wipe down surfaces regularly (keep wipes in the bathroom, for example).

Finally, don’t go to any crowded sporting events or shopping venues. Again: not the year for that. It’s just not worth the risk.

For more information on keeping your family safe this holiday season, visit the website of the Centers for Disease Control and Prevention or the Harvard Health Publishing Coronavirus Resource Center.

Follow me on Twitter @drClaire

The post Keeping your family safe this Thanksgiving appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/34CpV9E

Talking to your doctor about an abusive relationship

When Jayden called our clinic to talk about worsening migraines, a medication change was one potential outcome. But moments into our telehealth visit, it was clear that a cure for her problems couldn’t be found in a pill. “He’s out of control again,” she whispered, lips pressed to the phone speaker, “What can I do?”

Unfortunately, abusive relationships like Jayden’s are incredibly common. Intimate partner violence (IPV) harms one in four women and one in 10 men in the United States. People sometimes think that abusive relationships only happen between men and women. But this type of violence can occur between people of any gender and sexual orientation.

Experiencing abuse can be extremely isolating, and can make you feel hopeless. But it is possible to live a life free from violence. Support and resources are available to guide you towards safety — and your doctor or health professional may be able to help in ways described below.

What is intimate partner violence?

Intimate partner violence (IPV) isn’t just physical abuse like kicking or choking, though it can include physical harm. IPV is any emotional, psychological, sexual, or physical way your partner may hurt and/or control you. This can include sexual harassment, threats to harm you, stalking, or controlling behaviors such as restricting access to bank accounts, children, friends, or family.

If this sounds like your relationship, consider talking to your doctor or health care professional, or contact the National Domestic Violence Hotline at 800-799-SAFE.

What does a healthy relationship look like?

Media images show us uniformly blissful relationships, but perfect relationships are a myth. This culture can make it difficult for us to recognize unhealthy characteristics in our own relationships. Respect, trust, open communication, and shared decisions are part of a healthy relationship. You should be able to freely participate in leisure activities or see friends without fear of your partner’s reaction. You should be able to share your opinions or make decisions without fear of retaliation or abuse. Sexual and physical intimacy should include consent — meaning that no one uses force or guilt to compel you to do things that hurt you or make you feel uncomfortable.

How can a health professional help me?

Health professionals like doctors or nurses can take a history and assess how the abuse may be affecting your health, well-being, and safety. Trauma from IPV can cause visible symptoms, like bruises or scars, as well as more subtle symptoms, like abdominal pain, headaches, trouble sleeping, or symptoms of traumatic brain injury. Health professionals can also provide referrals to see specialists, if needed.

With your consent, health professionals can take a detailed history, examine you, and document the exam findings in your confidential medical record. Let them know if you are concerned that your partner will view your medical record, so measures can be taken to keep it confidential. This documentation can help to strengthen a court case if you decide to pursue legal action in the future.

Additionally, you may be at risk for pregnancy or certain sexually transmitted infections (STIs). A health professional can perform tests for STIs or pregnancy and offer birth control options. Some forms of birth control are less easily detected by your partner, like an IUD, or a contraceptive implant or injection.

Health professionals can help you develop a safety plan if you feel unsafe. They can also help connect you with social services, legal services, and specially trained advocates. If you would like, health professionals can also connect you with law enforcement to file a report.

What is a sexual assault exam?

If you have experienced sexual assault within 120 hours (five days), you may be offered a sexual assault medical examination. This exam is voluntary. It is performed by a trained health professional and may include a full body exam, including your vagina, penis, or anus. It may also include taking blood, urine, or body surface samples and/or photographs that could be used during an investigation or legal action. You may be prescribed medication that could prevent infections or a pregnancy. You can click here to learn more about the sexual assault exam.

What can I expect if I talk to a health care professional about IPV?

Health professionals should listen to you supportively and without judgement. While not all health professionals are trained in trauma-informed care, it is your right to be treated with respect and empathy to help you feel safe and empowered. You should not be pressured to do anything you don’t want to do. And this shouldn’t change the care you receive. You have the right to decline any care you are not comfortable with. You get to decide how you want to proceed after you share information with your healthcare professional, whether that means seeking out legal support, making a safety plan to leave the relationship, or choosing to stay in the relationship and be connected to ongoing support. And you can choose not to share information about abuse at all.

Will the conversation be private and confidential?

These discussions should occur with you and your health professional in a private space. If your abusive partner accompanies you to your appointment, your health professional may ask them to leave the examination room for a period of time so that you have the privacy to talk openly. You can also ask to speak with the health professional alone.

In most cases, discussing your experiences with your health professional is confidential under HIPAA. All states have laws that protect children, elders and people with disabilities from abuse of any kind. Your health professional is obligated in certain circumstances to report abuse, such as violence against a minor or vulnerable adult. However, only a few states require health professionals to report intimate partner abuse.

Where can I find more resources on IPV?

Want to learn more about IPV and how to seek help?

If you or someone you know you is at risk, call the National Domestic Violence Hotline at 800-799-SAFE (7233) or 800-787-3224. This hotline is for anyone, regardless of race, sex, ethnicity, gender identity, sexual orientation, religion, or ability.

If you are unable to speak safely, you can visit thehotline.org or text LOVEIS to 22522. They are available 24/7 by phone or with a live chat, and can work with you to find help in your area.

The post Talking to your doctor about an abusive relationship appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/2TwTuTI

Mind-body medicine in addiction recovery

As someone who struggled with a miserable opiate addiction for 10 years, and who has treated hundreds of people for various addictions, I am increasingly impressed with the ways in which mind-body medicine can be a critical component of recovery from addiction. Mind-body medicine is the use of behavioral and lifestyle interventions, such as meditation, relaxation, yoga, acupuncture, and mindfulness, to holistically address medical problems. Mind-body treatments can be integrated with traditional medical treatments, or used as standalone treatments for certain conditions. Mind-body medicine is now being studied by the National Institutes of Health and effectively used in the treatment of addiction, and it will likely play a role in addiction recovery programs in the future.

Mind-body principles are not new to the recovery movement

Mind-body principles have been around since the start of the recovery movement in 1937, and they are a big part of Alcoholics Anonymous. The 12 Steps of AA feature concepts such as surrender, meditation, gratitude, and letting go — all critical components of mind-body medicine. Most 12-step meetings end with the Serenity Prayer: “God, grand me the serenity to accept the things I cannot change, the courage to change the things I can, and the wisdom to know the difference.” Mutual help groups play a role in recovery for many people, and the principles of mindfulness that are part of these programs — in addition to the social support — shouldn’t be overlooked.

My experience with mind-body therapies for addiction

When I was sent to rehab for 90 days by the medical board due to my addiction, we participated in a lot of activities that seemed to be meant to approximate mind-body medicine, but they were haphazard and not particularly scientific, and I don’t believe they had the intended effect or were at all therapeutic. For example, we did shrubbery mazes (I’d get lost); we sat meditatively in silence (everyone around me chain-smoked, triggering my asthma); we had repeated lectures about “letting go and letting God” (I still have no idea what this means); we’d spend 30 minutes staring at a red square projected onto a screen (this gave me a migraine); and we went to a local acupuncture place where they hooked up extra electric current to the needles to give us extra “chi” (I felt like I was being cooked for dinner). Given that rehab is a $50 billion industry, I felt this was a lost opportunity to utilize mind-body medicine in a way that wasn’t superficial or trivial.

Formal mind-body therapies for addiction are being rigorously studied

Fortunately, there are now several scientifically-based mind-body medicine options for people in recovery. Mindfulness-Based Relapse Prevention (MBRP) is a technique that uses meditation as well as cognitive approaches to prevent relapse. It aims to cultivate awareness of cues and triggers so that one doesn’t instinctively turn to using drugs. It also helps people get comfortable sitting with unpleasant emotions and thoughts —their distress tolerance, a person’s ability to tolerate emotional discomfort — without automatically escaping by taking a drug. Improving distress tolerance is a common theme to many, if not all, approaches to addiction recovery, as a large part of the appeal of drug use is replacing a bad emotion with a good emotion — for example, by using a drug.

Mindfulness-Oriented Recovery Enhancement (MORE) is another technique to address addiction in recovery. MORE attempts to use both mindfulness and positive psychology to address the underlying distress that caused the addiction in the first place. There are three main pillars of MORE: it has been proven to help with distress tolerance; cue reactivity (the way people with addiction respond to cues, such as seeing a bottle of prescription drugs, which often trigger cravings); and attentional bias (the way an addicted brain will pay extra, selective attention to certain things, such as a pack of cigarettes when one is quitting smoking).

Mindfulness-Based Addiction Therapy (MBAT) is a technique that uses mindfulness to teach clients how to notice current emotions and sensations, and how to detach themselves from the urge to use drugs. This is called “urge surfing,” and we practiced it extensively in rehab. The aim is to break the automatic link between feeling uncomfortable, craving drugs, and, without thought or reflection, taking a drug to alleviate that discomfort.

Is there good evidence for mind-body medicine approaches to recovery?

While there is promising research that mind-body treatments for addiction are effective, some of the research is contradictory. According to a meta-analysis in the Journal of Substance Abuse Treatment, mindfulness is a positive intervention for substance use disorders, it has a significant but small effect on reducing substance misuse, a substantial effect on reducing cravings, and, importantly, it is a treatment that has a large effect on reducing levels of stress.

However, not all studies of mind-body medicine for addiction have shown overwhelmingly positive results. Some studies showed that the treatment gains diminish over time. Some randomized controlled trials did not show that mind-body medicine was better than cognitive behavioral therapy in decreasing alcohol and cocaine use, or in abstaining from cigarette use.

The National Center for Complementary and Integrative Health did a thorough review of much of the current literature surrounding mind-body medicine as it applies to addiction treatment, and summarized the impact of certain mind-body treatments as follows:

  • Acupuncture is generally safe, and may help with withdrawal, cravings, and anxiety, but there is little evidence that it directly impacts actual substance use.
  • There was some evidence that hypnotherapy my improve smoking cessation.
  • Mindfulness-based interventions can reduce the use of substances including alcohol, cocaine, marijuana, cigarettes, opiates, and amphetamines greater than control therapies do, and are also associated with a reduction in cravings and risk of relapse. But the data in several studies are not strong.

At this time, we need more and better evidence, and more definitive conclusions, about how helpful, ultimately, mind-body medicine will be in helping to treat addiction in different treatment settings. But a takeaway message is that mindfulness-based treatments are certainly quite effective as adjunct treatments for addiction, in that they can help people with their anxiety, distress tolerance, and cravings, and quite plausibly will turn out to help people put down the drink or the drug, and to avoid relapsing, once they have managed to get themselves into recovery.

Mind-body interventions to prevent addiction

If mind-body medicine can significantly reduce stress, then one must ask if it can also help us prevent addiction by helping our society deal with the chronic, overwhelming stress that it is facing. Addiction is in large part considered to be a “disease of despair.” Important contributors to addiction are untreated anxiety and depression, unresolved childhood trauma, social isolation, and poor distress tolerance. If all of us can learn, or be trained, to be more mindful, grateful, present, and connected, perhaps the need, and eventually the habit, of fulfilling our most basic needs with the false promise of a chemical that merely wears off — and leaves us worse off — will become less of a problem in our society.

The post Mind-body medicine in addiction recovery appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/2HGqNks

What your skin should expect when you’re expecting

Are you pregnant or thinking of becoming pregnant? You’re probably prepared for morning sickness, weight gain, and an expanding belly. But did you know your skin can also undergo a variety of changes when you’re expecting? These changes are due to normal alterations in hormones that occur during pregnancy. Rest assured, most skin conditions that develop or worsen during pregnancy are benign, and tend to improve following delivery.

Darkening of the skin

A large majority of women experience darkening of their skin due to hormone shifts that occur during pregnancy. You may notice that the areas around your thighs, genitals, neck, armpits, and nipples darken. Many women also develop linea nigra, a dark line extending between the belly button and pubic bone. It is also not uncommon for women to experience darkening of their pre-existing moles and freckles. (If you are concerned that a spot on your body is growing or changing more than you’d expect, see a dermatologist for further evaluation.) However, most pigmentary changes tend to return to normal following childbirth, but may take many months to do so.

Melasma, the “mask of pregnancy”

Perhaps the most cosmetically distressing pigmentary change to occur in pregnancy is melasma, also known as the “mask of pregnancy.” Melasma, which can appear as dark patches on the forehead, cheeks, and upper lip, develops in approximately 70% of pregnant women. Melasma is exacerbated by exposure to sunlight. To help prevent it, consistently use sunscreens with sun protection factor (SPF) greater than 50, wear sun-protective clothing and hats when spending time outdoors, and avoid too much direct sunlight.

Melasma can sometimes persist after delivery, though it tends to improve after childbirth. If you wish to treat melasma after delivery, there are many treatments that can be prescribed or performed by a dermatologist, including skin lightening agents, chemical peels, and certain types of lasers. Hydroquinone, which is one of the most commonly used lightening agents on the market, is not safe to use during pregnancy or while breastfeeding. If you want to use a cream that has brightening properties while pregnant, look for glycolic acid or azelaic acid in the ingredient list.

Stretch marks

Stretch marks, also called striae gravidarum, are pink or white streaks of thin skin that develop in up to 90% of pregnant women. They occur due to expansion and stretching of skin during pregnancy, and they are most frequently seen on the abdomen, breasts, buttocks and hips. Stretch marks tend to develop in the late second and third trimester.

Many treatments, including vitamin E-containing oils, olive oil, and cocoa butter, have been used for prevention and treatment of striae, but unfortunately there is limited data to suggest the that any of these products are truly effective. These pink or red marks tend to fade to skin color following delivery, although they rarely disappear entirely. Evidence suggests that topical hyaluronic acid, tretinoin, and trofolastin can be used, with varying degrees of success, after delivery. If topicals are not effective, research has shown that several laser treatments, energy-based devices, and microneedling can lead to visible improvement in striae by increasing production of collagen (a structural component of skin) and decreasing blood flow to the lesions.

Acne… again?!

Many women experience breakouts during their pregnancies, especially those who had acne prior to pregnancy. This typically occurs in the first trimester and is related to the surge of estrogen causing overproduction in oil glands. Guidelines for the treatment of acne during pregnancy are scarce due to the lack of safety data. Dermatologists often recommend a combination of topical azelaic acid and/or benzoyl peroxide. If these treatments are not effective, topical antibiotics such as erythromycin or clindamycin can be added in some cases. Oral antibiotics, including erythromycin, azithromycin, and cephalexin, may be used for persistent cases. Oral and topical retinoids, normally a mainstay of treatment for moderate to severe acne, can result in birth defects and should be avoided during pregnancy.

If you develop any skin eruptions during pregnancy that cause concern, you should be evaluated by a dermatologist prior to starting any medications.

Follow me on Twitter @KristinaLiuMD

The post What your skin should expect when you’re expecting appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3mkNEBc

Aspirin and breast cancer risk: How a wonder drug may become more wonderful

Aspirin has been called a wonder drug. And it’s easy to see why.

It’s inexpensive, its side effects are well-known and generally minor. And since it was developed in the 1890s, it’s been shown to provide a number of potential benefits, such as relieving pain, bringing down a fever, and preventing heart attacks and strokes. Over the last 20 years or so, the list of aspirin’s potential benefits has been growing. And it might be about to get even longer: did you know that aspirin may lower your risk of several types of cancer?

Studies of aspirin and cancer

A number of studies suggest that aspirin can lower the risk of certain types of cancer, including those involving the

The evidence that aspirin can reduce the risk of colon cancer is so strong that guidelines recommend daily aspirin use for certain groups of people to prevent colon cancer, including adults ages 50 to 59 with cardiovascular risk factors, and those with an inherited tendency to develop colon polyps and cancer.

And what about breast cancer? A number of studies in recent years suggest that breast cancer should be added to this list.

Studies of aspirin and breast cancer

One of the more convincing studies linking aspirin use to a lower risk of breast cancer followed more than 57,000 women who were surveyed about their health. Eight years later, about 3% of them had been newly diagnosed with breast cancer. Those who reported taking low-dose aspirin (81 mg) at least three days a week had significantly fewer breast cancers.

  • Regular low-dose aspirin use was associated with a 16% lower risk of breast cancer.
  • The reduction in risk was even greater — about 20% — for a common type of breast cancer fueled by hormones, called HR positive/HER2 negative.
  • No significant reduction in risk was found among those taking regular-dose aspirin (325 mg), or other anti-inflammatory medications such as ibuprofen.

Another analysis reviewed the findings of 13 previous studies that included more than 850,000 women and found

  • a 14% lower risk after five years of taking aspirin
  • a 27% lower risk after 10 years of aspirin use
  • a 46% reduction in risk after 20 years of aspirin use.

How does aspirin affect breast cancer risk?

These studies did not examine why or how aspirin might reduce breast cancer risk. So we really don’t how it might work.

In animal studies of breast cancer, aspirin has demonstrated anti-tumor properties, including inhibiting tumor cell division and impairing growth of precancerous cells. In humans, researchers have observed an anti-estrogen effect of aspirin. That could be important, because estrogen encourages the growth of some breast cancers. It’s also possible that aspirin inhibits new blood vessel formation that breast cancers need to grow. And the particular genetics of the tumor cells may be important, as aspirin’s ability to suppress cancer cell growth appears to be greater in tumors with certain mutations.

Now what?

It’s too soon to suggest that women should take aspirin to prevent breast cancer. Studies like these can show a link between taking a medication (such as low-dose aspirin) and the risk of a particular condition (such as breast cancer), but cannot prove that aspirin actually caused the reduction in breast cancer risk. So we’ll need a proper clinical trial — one that compares rates of breast cancer among women randomly assigned to receive aspirin or placebo — to determine whether aspirin treatment lowers the risk of breast cancer.

Warning: All drugs come with side effects

Keep in mind that all medications, including aspirin, can cause side effects. While aspirin is generally considered safe, it can cause gastrointestinal ulcers, bleeding, and allergic reactions. And aspirin is usually avoided in children and teens, due to the risk of a rare but serious condition called Reye’s syndrome that can harm the brain, liver, and other organs.

Stay tuned

Low-dose aspirin is often prescribed to help treat or prevent cardiovascular disease, such as heart disease and strokes. A 2016 study estimated that if more people took aspirin as recommended for cardiovascular disease treatment or prevention, hundreds of thousands of lives and billions of dollars in healthcare costs would be saved. That might be an underestimate if the drug’s anti-cancer effects are confirmed. But aspirin is not beneficial for everyone — and some people need to avoid taking it. So, ask your doctor if taking aspirin regularly is a good idea for you.

Follow me on Twitter @RobShmerling.

The post Aspirin and breast cancer risk: How a wonder drug may become more wonderful appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3jhLn7W

Promoting equity and community health in the COVID-19 pandemic

Editor’s note: Second in a series on the impact of COVID-19 on communities of color, and responses aimed at improving health equity. Click here to read part one.

In early March 2020, as COVID-19 was declared a public health emergency in Boston, Mass General Brigham began to care for a growing number of patients with COVID-19. Even at this early stage in the pandemic, a few things were clear: our data showed that Black, Hispanic, and non-English speaking patients were testing positive and being hospitalized at the highest rates. There were large differences in COVID-19 infection rates among communities. Across the river from Boston, the city of Chelsea began reporting the highest infection rate in Massachusetts. Within Boston, several neighborhoods, including Hyde Park, Roxbury, and Dorchester, exhibited infection rates double or triple the rest of the city. COVID-19 was disproportionately harming minority and vulnerable communities.

Working toward an equitable response to COVID-19

From the start, our work was driven by examining COVID data by race, ethnicity, language, disability, gender, age, and community. As the COVID crisis intensified in Massachusetts, we sought ways to improve health equity and extend support within the communities we serve. We designed and deployed initiatives aimed at our patients, community members, and employees. Below are examples of tools to enhance equity that we found useful.

Communicating with patients

As new COVID care models were established, we worked on access to clinical communication for all patients and their families. There was a particular focus on language, since COVID greatly impacted non-English speaking communities, and on communication for people with disabilities.

  • We linked COVID operations, such as our nurse hotline and telemedicine platforms, to interpreter services or bilingual staff, supported by patient tip sheets in multiple languages. Interpreters, working virtually through enhanced technology and remote communication, supported patients and families with limited English proficiency.
  • We collected information on clinical and administrative staff language proficiency, so that multilingual staff could help guide patient care. For example, at two hospitals we established a care model of Spanish-speaking physicians to provide cultural and linguistic support in inpatient and intensive care units that complemented interpreter services.
  • As all staff and patients began wearing masks, we ensured that deaf or hard-of-hearing patients would be able to communicate with care teams through the use of masks with a clear window, to allow for lip reading.

Providing up-to-date information for patients and employees

Guidance on how to protect yourself from COVID-19 evolved rapidly. Limited English proficiency, limited access to the Internet or to smartphones and computers, and limited tech savvy are barriers to receiving information for many of our patients and employees. We needed to identify ways to ensure that rapidly changing health information was available to everyone.

  • For our patients, we created COVID education in multiple languages, which was distributed through various modes, including brief videos. We also sent text messages with COVID alerts to more than 100,000 of our patients who live in hot-spot communities, or who were not enrolled in our patient portal.
  • For our employees, we initially hosted socially-distanced, in-person educational sessions in multiple languages. These sessions provided COVID education and updates on infection control protocol and human resources policies. Our employee educational effort later shifted to a remote model by enrolling 5,500 employees who do not use computers as part of their normal job function (such as environmental services and nutrition and food services staff) into a multilingual texting campaign designed to provide key information.

Expanding equity within communities

Through the COVID pandemic, we were building on our existing presence in, and partnerships with, the communities we serve in eastern Massachusetts in several ways.

  • Community members lacked necessary supplies to protect themselves from COVID, such as masks. In April, we launched the production of care kits — packages which included masks, hand sanitizer, soap, and patient education materials — and distributed them within our communities at locations such as COVID testing centers, food distribution sites, and housing authorities. To date, more than 175,000 care kits have been distributed, including more than 1.3 million masks.
  • We also partnered with community leaders to provide COVID education. We identified trusted community leaders to record and release brief educational videos over social media to reinforce wearing masks, social distancing, and washing hands.
  • Finally, through screening for social determinants of health, it became clear that many of our most vulnerable communities were reporting high rates of food insecurity. We coupled longstanding efforts to address unmet health-related social needs among our patients and communities with our COVID response, by distributing grocery bags and meals at several COVID testing sites.

Looking forward

We made it through the peak of the pandemic in Massachusetts, launching a suite of initiatives to address inequity within Mass General Brigham’s COVID response. However, the battle is by no means over. Now is the time for action. Even in states like Massachusetts, where infections, hospitalizations, and deaths have substantially declined in recent months, we need to ready ourselves for a resurgence — one that is already occurring in parts of the US and Europe. Surveillance and early preparation are key. Increased prevention and mitigation efforts, widespread testing, and identification of emerging hot spots can help curb the impact of a fall and winter resurgence of the virus. Unless we act now, and unless we ramp up efforts aimed at improving health equity, this will once again hit minority communities hardest.

The post Promoting equity and community health in the COVID-19 pandemic appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3orXgfo

Communities of color devastated by COVID-19: Shifting the narrative

Editor’s note: First in a series on the impact of COVID-19 on communities of color and responses aimed at improving health equity.

By now we’ve read headlines like these all too often: “Communities of Color Devastated by COVID-19.” Way back in March, available data started to show that vulnerable, minority communities were experiencing much higher rates of infection and hospitalization from COVID-19 than their white counterparts. New York City, New Orleans, Chicago, Detroit, Milwaukee, and Boston, where I live and work, all became ground zeros in our nation’s early battle with the pandemic. The numbers were astounding: Blacks and Latinos were four to nine times more likely to be infected by COVID than whites, even in our nation’s top hot spots. Was I surprised? Absolutely not.

A long view on health disparities

I’m originally from Puerto Rico, and grew up in a bilingual, bicultural home where I had a ringside seat to witness how the issues of race, ethnicity, culture, and language barriers intersected with all aspects of society. Currently, I’m a practicing internist at Massachusetts General Hospital (MGH), where I founded the MGH Disparities Solutions Center in 2005, which I led until becoming the Chief Equity and Inclusion Officer for the hospital last year. I’ve studied and developed interventions to address disparities in health and health care for more than two decades. My career has connected me to more than 100 hospitals in 33 states that are actively engaged in efforts to improve quality, eliminate racial and ethnic disparities in care, and achieve health equity. So, addressing disparities in care isn’t just a job for me; it’s my profession and my passion.

History teaches us that disasters — natural or man-made — always disproportionately harm vulnerable and minority populations. Think of Hurricane Katrina in New Orleans. Those with lower socioeconomic status, who were predominately Black, lived in lower-lying areas with limited protections against flooding, including levees that hadn’t been upgraded or reinforced. Multiple factors converged during and after the storm to rain down unprecedented damage and destruction on these communities, compared with white communities with higher socioeconomic status.

A shifting, yet familiar story of health disparities unspools

Fast-forward to the early months of this devastating pandemic. Working alongside many talented colleagues, I led the combined Mass General Brigham and Equity COVID Response efforts at MGH. Hospitals around the country quickly learned that people with chronic conditions such as diabetes, lung disease, and heart disease, and those of advanced age, had a poorer prognosis once infected with COVID-19.

In the United States, these chronic conditions disproportionately affect minority populations. So, minorities entered the pandemic with a long history of health disparities that put them at a disadvantage. Structural racism, discrimination, and the negative impact of the social determinants of health — including lower socioeconomic status, less access to education, hazardous environments — continuously undermine the health and well-being of these communities. This is compounded by minorities having less access to health care, and, when they are able to see a health care provider, often engaging with significant mistrust, or language barriers, that make it difficult to obtain high-quality care.

We quickly saw the importance of effective public health messaging, delivered by trusted messengers. However, in minority communities, where mistrust prevails due to historic racism, and limited English proficiency is common, these messages, and the appropriate messengers, weren’t available.

Multicultural media tried its best. But a lack of physicians of color to deliver key messages, and a lot of messages being delivered in English, created a vacuum in good information. Not surprisingly, this was filled by misinformation. So, many communities didn’t get important information early, shared by someone they could trust and easily understand, and presented in their language. Time lost led to lives lost.

Physical structures of systemic inequities helped drive illnesses and deaths

COVID-19 is a respiratory virus that is easily spread from person to person through droplets, and aerosols produced when people breathe, talk, cough, or even sing. This means proximity increases risk, thus the push to social distance, and more recent mandates about wearing masks. To make matters more complicated, a person can have COVID-19 for 10 to 14 days and be asymptomatic, spreading the virus easily and unknowingly to friends, family, coworkers, and those who stood close by on public transportation.

So, what have we learned since last spring about who is at highest risk for COVID-19? It’s those who live in densely populated areas; those who have multiple and multigenerational households in small living spaces; those deemed essential workers — health care support services, food services, and more — who don’t have the luxury to work from home, have groceries delivered, or socially isolate themselves; and those who depend on public transportation to get to work, and thus can’t travel safely in their car, or afford parking when they get to work.

Minorities aren’t more genetically susceptible to COVID-19. Instead, all of the factors described here are the social conditions in which minorities and vulnerable communities are more likely to live and move around in this world every day. Only by building from this understanding can we hope to shift the narrative, and change the headlines before cases surge this winter.

The post Communities of color devastated by COVID-19: Shifting the narrative appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/2HwBwO8

Illness-related fatigue: More than just feeling tired

A common refrain during the COVID-19 pandemic is, “I’m so tired.” After months of adjusted living and anxiety, people are understandably weary. Parents who haven’t had a break from their kids are worn out. Those trying to juggle working from home with homeschooling are stretched thin. Between concerns about health, finances, and isolation, everyone is feeling some level of additional stress during this unusual time, and that’s tiring. We all could use a good, long nap — or better yet, a vacation.

But while a break would be nice, most people — except those who are actually sick with COVID-19 or other illnesses — are able to push through their fatigue, precisely because they aren’t sick. “Tired” is a nebulous word that covers a broad spectrum of levels of fatigue. A crucial distinction, however, is between regular fatigue and illness-related fatigue.

Regular fatigue

Everyday fatigue that is not illness-related starts with a baseline of health. You may feel sleepy, you may in fact be sleep-deprived, or your body and mind may be worn out from long hours, exertion, or unrelenting stress — but you don’t feel sick. Your muscles and joints don’t ache like when you have the flu. You are capable of getting out of bed and powering through the day, even if you don’t want to. A cup of coffee or a nap might perk you up.

This type of fatigue is usually related to external factors: lack of sleep, stress, an extra-hard workout. But internally, your body is working well: your glands and organs are operating properly; infection is not depleting your body of energy; your nervous system may be overtaxed, but it’s not frayed from actual impairment.

Illness-related fatigue

When I was acutely ill with persistent Lyme, babesiosis, and ehrlichiosis (all tick-borne illnesses), as well as chronic Epstein-Barr virus, a good night’s sleep did nothing. Naps were staples of my day that helped me survive but didn’t improve my energy. Drinking a cup of coffee was akin to treating an ear infection with candy. No matter how much I rested, my exhaustion persisted.

I felt like I had the flu, except it lasted for years. My whole body ached. I suffered migraine headaches. I had hallucinogenic nightmares. Exercise was out of the question; at times, I was literally too tired to walk up a flight of stairs or sit at the dinner table. I couldn’t concentrate, unable to read or watch TV. Sometimes I was too tired to talk.

There was no pushing through this level of fatigue, because it was caused by internal factors: illnesses that were ravaging my body. Only when they were adequately treated did I start to get my energy back.

For me, the root causes were bacterial infections (Lyme, ehrlichiosis), a parasite (babesiosis), and a virus (Epstein-Barr). Profound fatigue may also result from a host of other diseases and conditions, including chronic fatigue syndrome, fibromyalgia, and multiple sclerosis.

Is it everyday fatigue or illness-related fatigue?

When determining whether your tiredness is everyday fatigue or illness-related, consider the following questions:

  • Do you feel worn out, or do you feel sick?
  • Have you experienced this before, or does it feel more extreme or unrelenting?
  • When you lessen the load of external factors (work, stress, long days) does the fatigue improve, or does it persist?
  • Do you feel refreshed after a good night’s sleep or a nap?
  • Can you go about your day, or is it impossible to get out of bed?
  • Has the fatigue persisted longer than you would expect?
  • Are you experiencing other symptoms that might point to illness?

The bottom line

No one knows your body better than you do. You know what feels normal, and you know what you feel like when you’re sick. If you are not responding to regular fatigue remedies, your fatigue has persisted over time, you have other symptoms, or you just don’t feel right, it’s probably time to call your doctor.

The post Illness-related fatigue: More than just feeling tired appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/37rNt2F

Beyond trick-or-treating: Safe Halloween fun during the COVID-19 pandemic

Since the beginning of the pandemic, we’ve had to find new ways to do almost everything — and the same is true of this year’s Halloween celebrations.

Two mainstays of Halloween, trick-or-treating and Halloween parties, could be very risky this year. Going from house to house, sticking your hands in bowls of candy that many other hands have touched, or being close to people indoors or out, are all activities that could spread the virus. Even if people feel perfectly well, there’s no guarantee that they aren’t sick, and therefore contagious.

That doesn’t mean we have to ditch Halloween entirely. On the contrary, we need some fun — and as much as we can, we need to keep some traditions. We just need to do some tweaking to make Halloween not only fun but safe. The fact that Halloween falls on a Saturday this year is helpful: you can truly make a day of it, and there’s less worry about getting to bed on time.

A fun and safe Halloween

If you think about what makes Halloween fun, it’s dressing up and showing off our costumes, carving pumpkins, being spooked — and, of course, eating candy. With some creativity, we can do all of those things safely.

The safest thing to do is celebrate at home with your family (or the people in your bubble). That way you don’t have to take any risks. You could:

  • Make a really big deal out of carving pumpkins — or decorating them, for those who can’t or shouldn’t use knives. Use markers, paint, anything you can find. Take pictures. Have a contest.
  • Decorate your house and yard with spooky things. You could make your own haunted house.
  • Wear your costume all day at home. Usually you’d wear it for just trick-or-treating or parties; make the day more special by having everyone in costume (and pretending to be whatever they are dressed up as) all day.
  • Have a virtual costume-sharing party with friends and family. If you can’t organize that, do video calls with every last person you can think of.
  • Instead of trick-or-treating, hide the candy around your home and/or yard, like an Easter egg hunt. If you do it right, the kids can spend hours looking for it (and you’ll probably be finding it for months).
  • Curl up together and have a spooky movie night. Let the kids stay up later than usual (that generally makes kids happy).

Staying safe outside

  • If you do go out of the house, look for a community event or party that is outdoors and allows for social distancing. Pay attention to guidelines in your community that limit the number of people, even at events held outside.
  • Make sure you are wearing a mask –– you could make it part of your costume. Just remember that costume masks do not take the place of multilayer fabric masks that cover your mouth and nose.
  • Carry hand sanitizer and wipes with you.
  • If things are getting crowded and social distancing is getting hard, or people are taking off their masks or not wearing them at all, leave. It’s just not worth the risk.

This really isn’t the year for trick-or-treating; many areas have banned it. If you decide to take that risk, you should all wear masks as described above, limit yourself to a small number of homes of people you know, and keep your distance from them as much as you can. Wear gloves, and when you get home, wipe down the candy wrappers.

You may want to discourage trick-or-treaters at your house by keeping the lights out or putting up a sign (“We are busy playing games with ghosts this year — see you next year!” or something like that). If you do decide to give out treats, consider putting them in separate bags that are easy for people to grab, and leaving them outside your door. You could sit outside with them and greet people, but do so from a distance (and with a mask).

For more information about how to celebrate Halloween safely, check out the websites of the American Academy of Pediatrics and the Centers for Disease Control and Prevention.

Follow me on Twitter @drClaire

The post Beyond trick-or-treating: Safe Halloween fun during the COVID-19 pandemic appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3o9HpSA

Coping with the loss of smell and taste

As I cut a slice of lemon for my tea one morning last March, I found that I could not detect the familiar zing of citrus. Nor, it turned out, could I taste the peach jam on my toast. Overnight, my senses of smell and taste seemed to have disappeared. In the days prior to that I’d had body aches and chills, which I ascribed to a late-winter cold — nothing, I thought, an analgesic and some down time couldn’t take care of. But later that day I saw a newspaper article about the loss of smell and taste in patients with COVID-19, and I realized that I’d likely caught the virus. While I was fortunate enough to eventually recover from it without a trip to the hospital or worse, months after testing negative for COVID, my senses of both smell and taste are still not fully recovered.

In this, I know, I’m hardly alone. According to US News and World Report, 86% of patients with mild to moderate COVID-19 — over six million people, all told — reported problems with their sense of smell, while a similar percentage had changes in taste perception. (Taste and smell work together to create the perception of flavor.) This is in addition to the 13.3 million Americans diagnosed with anosmia — a medical term for the loss of smell — related to other respiratory viruses, head injuries, and other causes. For many of us, improvement has been slow.

Loss of smell affects our health and quality of life

Our senses — smell, vision, hearing, taste, and touch — are bridges that connect us to the world we live in, to life itself. Knock out two of the five bridges, and 40% of our sensory input is gone. Senses add richness and texture to everyday life; they are intricately tied in with our emotions. The loss of smell or taste might not seem as drastic as the shortness of breath or debilitating fatigue that many other people have experienced post-COVID, yet the impact can still be quite demoralizing. You can no longer smell the familiar scent of your loved ones, or taste your favorite dish. Author and poet Diane Ackerman describes these special tastes and smells as “the heady succulence of life” itself.

The loss of smell and taste can also affect our health, causing poor appetite and undesired weight loss. No longer able to enjoy food, patients with anosmia may no longer eat enough, or skip meals altogether. It can even pose an existential threat, by putting us at risk in detecting fires, gas leaks, or spoiled food.

All these impacts help explain why recent studies have linked post-COVID anosmia to depression and anxiety. The jury is still out on whether this has to do with the loss of smell or taste per se — or with the impact of the virus on the central nervous system. One thing we know for sure, however: mood and sense of smell are intricately related. The 5,000-plus members of the Facebook group for post-COVID anosmia sufferers can attest to that. Feelings expressed in their posts run the gamut from mere wistfulness to full-blown grief.

Recovering from the loss

The good news is that olfactory neurons are capable of regeneration. The bad news is that not everyone will return to his or her pre-COVID level of functioning. And, sadly, some of us might never regain our sense of smell or taste at all. According to some experts, patients with post-viral loss of smell have roughly a 60% to 80% chance of regaining some of their smell function within a year. Since the sense of smell usually diminishes due to age, the recovery could take longer and be less than complete for older adults.

Savor what you can experience and engage the mind

To reawaken the olfactory nerves, most specialists recommend smell training, a daily routine of sniffing essential oils such as lemon, eucalyptus, cloves, rose, and others. If you suffer from olfactory loss, don’t be discouraged if some of the essences smell different from what you expected: distortions associated with the loss of smell (troposmia) are not uncommon.

The principle of mindfulness plays an important role here. If you cannot smell the essence at all, try and remember the smell; in other words, engage your mind in evoking the sensation. When eating, if you cannot taste the full range of flavors of a dish, pay attention to the basic ones — sweet, bitter, sour, salty, or umami — as well as to the food’s texture and the sensation on your palate. This will help you focus on what you still can taste, rather than on what you cannot. When I eat dark chocolate, for example, I can taste only the bitter and the sweet; for the flavor of the cacao bean, I still have to rely on my memory.

The old adage, “What doesn’t kill me makes me stronger,” acquires a fresh meaning when applied to the losses associated with COVID-19. These losses challenge us to become more mindful and self-aware, and ultimately, more resilient. We must also learn to be patient and appreciate incremental bits of progress. The other day, for the first time in months, I caught a whiff of citrus in my tea. Lemon never smelled so sweet.

Tips and coping strategies

In my practice with patients with post-COVID losses, and in my own recovery, I have found the following coping strategies helpful.

  • Acknowledge your feelings about the loss.
  • Consult with an ear, nose, and throat specialist for guidance.
  • Consider adjusting your cooking in favor of spicier foods.
  • Maintain hope for recovery.
  • Cultivate a sense of gratitude: you have survived a potentially lethal disease.
  • For additional help, see a counselor or join a support group.

The post Coping with the loss of smell and taste appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3kdIFSd

Early, tight control of Crohn’s disease may have lasting benefits

The gastrointestinal (GI) tract is a remarkable organ: it resides on the inside of our bodies, but is regularly in contact with the outside world by virtue of what we ingest. It is quite incredible that the immune cells of the GI tract are not activated more regularly by the many foreign products it encounters every day. Only when the GI tract encounters an intruder that risks causing disease do the immune cells of the GI tract spring into action.

That is, of course, under normal circumstances. In people with Crohn’s disease, the normally tolerant immune cells of the GI tract are activated without provocation, and this activation leads to chronic or relapsing — but ultimately uncontrolled — inflammation.

Crohn’s disease: A primer

First described by Dr. Burrill B. Crohn and colleagues in 1932, Crohn’s disease is a complex inflammatory disorder that results from the misguided activity of the immune system. It can involve any part of the GI tract from the mouth to the anus, but most commonly involves the end of the small intestine.

Depending on the precise location of GI inflammation, Crohn’s disease may cause any number of symptoms including abdominal pain, diarrhea, weight loss, fever, and sometimes blood in the stool.

Treatment options for Crohn’s disease have evolved dramatically since Dr. Crohn and colleagues first described the condition, but the basic principle has remained the same: reduce the uncontrolled inflammation. Early approaches to treatment involved nonspecific anti-inflammatory medications such as corticosteroids, which have many potentially serious side effects outside the intestines.

Today, a number of newer therapies exist that act more specifically on the immune system to target inflammatory pathways known to be active in Crohn’s disease. These newer drugs, termed biologics, are antibodies that block proteins involved in specific inflammatory pathways relevant to Crohn’s disease. Since we don’t fully understand which pathways are involved in which patients, however, choosing a medication for a given patient is as much an art as it is a science.

Evidence grows for early, aggressive treatment of Crohn’s disease

Early approaches to treatment of Crohn’s disease followed a step-up algorithm in which the newer medications would only be used if the patient did not benefit from established therapies. This sequential approach — termed step therapy — has more recently been called into question, as studies have repeatedly shown that the newer drugs for Crohn’s disease are more effective than the old standards, and have preferable side effect profiles. Research also indicates that early, aggressive intervention and treatment, targeting not just symptoms but objective evidence of inflammation (as assessed through blood work, stool tests, imaging, and endoscopy), lead to better health and quality of life, at least in the short term.

Researchers recently published a study in the journal Gastroenterology on the longer-term benefits of treating Crohn’s patients to reduce both symptoms and inflammation. Specifically, they analyzed follow-up data from patients enrolled in the CALM study — a multicenter trial that compared two approaches to the treatment of early, moderate to severe Crohn’s disease. In the first approach, the decision to escalate therapy was based on symptoms alone; in the other approach, the decision was based on both symptoms and objective evidence of inflammation (found in blood work or a stool test, for example). This second approach is called tight control. A patient under tight control might feel well, but therapy would be escalated if there was objective evidence of inflammation. The primary end point of the original CALM study was healing the inflamed lining of the intestines, and the data showed that the tight control approach to treatment was more effective at reaching this goal.

The Gastroenterology study took the results of the original CALM study one step further. The researchers looked at how the patients who achieved healing of their intestinal lining are doing several years later. To this end, the researchers looked at the rates of various adverse outcomes (including the need for surgery and hospitalization for Crohn’s disease) in the CALM study patients since the trial ended.

They found that patients who were both feeling well and had demonstrated healing of the intestinal lining (called deep remission) had a significantly decreased risk of Crohn’s disease progression. Healing of the intestinal lining without feeling well, and feeling well without healing of the intestinal lining, were also associated with a lower risk of disease progression when compared to patients with active symptoms and inflammation, but to a lesser extent.

Study findings may not generalize to many Crohn’s disease patients

The recent study lends strength to a growing body of evidence in support of a treatment approach that emphasizes early intervention aimed at healing the lining of the intestines and resolving symptoms. Can we generalize the findings to most patients with Crohn’s disease? Not necessarily.

Enrolled patients had never been treated with a newer biologic drug, or with a drug called an immunomodulator that affects the way the immune system functions, before enrolling in the CALM study. Immunomodulators have been used to treat inflammatory bowel disease (IBD) since the 1960s, and they are often one of the first drug classes used for treatment of IBD. As a result, these study results may not generalize to the many people who have had a Crohn’s diagnosis for long enough to have already been treated with an immunomodulator.

Furthermore, those who received escalation of therapy were treated with increasingly optimized doses of a single biologic, adalimumab (Humira). It remains to be seen whether we would see the same results in patients already exposed to a biologic or with the use of another biologic.

Doctor-patient collaboration is critical for successful Crohn’s treatment

In my practice, I regularly encourage using highly effective therapies early to pursue tight control. For some, the decision to follow this approach is easy. For others, the idea of escalating therapy, perhaps in the absence of symptoms, and to target something they may not feel, is more difficult to be convinced of. Concerns about side effects and the need for frequent monitoring are paramount among the roadblocks.

Collaborating with my patients so that they can make medical decisions that are in line with their values but still informed by evidence is critical for success, as is a commitment to regularly revisit and rethink the approach over time.

The post Early, tight control of Crohn’s disease may have lasting benefits appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3m5tP0L

The tragedy of the post-COVID “long haulers”

Suppose you are suddenly are stricken with COVID-19. You become very ill for several weeks. On awakening every morning, you wonder if this day might be your last.

And then you begin to turn the corner. Every day your worst symptoms — the fever, the terrible cough, the breathlessness — get a little better. You are winning, beating a life-threatening disease, and you no longer wonder if each day might be your last. In another week or two, you’ll be your old self.

But weeks pass, and while the worst symptoms are gone, you’re not your old self — not even close. You can’t meet your responsibilities at home or at work: no energy. Even routine physical exertion, like vacuuming, leaves you feeling exhausted. You ache all over. You’re having trouble concentrating on anything, even watching TV; you’re unusually forgetful; you stumble over simple calculations. Your brain feels like it’s in a fog.

Your doctor congratulates you: the virus can no longer be detected in your body. That means you should be feeling fine. But you’re not feeling fine.

The doctor suggests that maybe the terrible experience of being ill with COVID-19 has left you a little depressed, or experiencing a little PTSD. Maybe some psychiatric treatment would help, since there’s nothing wrong with you physically. You try the treatment, and it doesn’t help.

How common are lingering COVID symptoms?

Tens of thousands of people in the United States have such a lingering illness following COVID-19. In the US, we call them post-COVID “long haulers.” In the United Kingdom, they are said to be suffering from “long COVID.”

Published studies (see here and here) and surveys conducted by patient groups indicate that 50% to 80% of patients continue to have bothersome symptoms three months after the onset of COVID-19 — even after tests no longer detect virus in their body.

Which lingering symptoms are common?

The most common symptoms are fatigue, body aches, shortness of breath, difficulty concentrating, inability to exercise, headache, and difficulty sleeping. Since COVID-19 is a new disease that began with an outbreak in China in December 2019, we have no information on long-term recovery rates.

Who is more likely to become a long hauler?

Currently, we can’t accurately predict who will become a long hauler. As a recent article in Science notes, people only mildly affected by COVID-19 still can have lingering symptoms, and people who were severely ill can be back to normal two months later. However, continued symptoms are more likely to occur in people over age 50, people with two or three chronic illnesses, and people who became very ill with COVID-19.

There is no formal definition of the term “post-COVID long haulers.” In my opinion, a reasonable definition would be anyone diagnosed with the coronavirus that causes COVID-19, or very likely to have been infected by it, who has not returned to their pre-COVID-19 level of health and function after six months.

Long-haulers include two groups of people affected by the virus:

  • Those who experience some permanent damage to their lungs, heart, kidneys, or brain that may affect their ability to function.
  • Those who continue to experience debilitating symptoms despite no detectable damage to these organs.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, has speculated that many in the second group will develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). ME/CFS can be triggered by other infectious illnesses — such as mononucleosis, Lyme disease, and severe acute respiratory syndrome (SARS), another coronavirus disease. The National Academy of Medicine estimates there are one million to two million people in the US with ME/CFS.

Dr. Tedros Ghebreyesus, director of the World Health Organization, also has expressed growing concern about the chronic illnesses that may follow in the wake of COVID-19, including ME/CFS.

What might cause the symptoms that plague long haulers?

Research is underway to test several theories. People with ME/CFS, and possibly the post-COVID long haulers, may have an ongoing low level of inflammation in the brain, or decreased blood flow to the brain, or an autoimmune condition in which the body makes antibodies that attack the brain, or several of these abnormalities.

The bottom line

How many people may become long haulers? We can only guess. Right now, more than seven million Americans have been infected by the virus. It’s not unthinkable that 50 million Americans will ultimately become infected. If just 5% develop lingering symptoms, and if most of those with symptoms have ME/CFS, we would double the number of Americans suffering from ME/CFS in the next two years. Most people who developed ME/CFS before COVID-19 remain ill for many decades. Only time will tell if this proves true for the post-COVID cases of ME/CFS.

For this and many other reasons, the strain on the American health care system and economy from the pandemic will not end soon, even if we develop and deploy a very effective vaccine by the end of 2021.

Virtually every health professional I know believes that the pandemic in the US could and should have been better controlled than it has been. Bad mistakes rarely lead to only temporary damage.

The post The tragedy of the post-COVID “long haulers” appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3k1tivW

Stopping osteoarthritis: Could recent heart research provide a clue?

Here’s a recent headline that I found confusing: Could the first drug that slows arthritis be here?

It’s confusing because it depends on which of the more than 100 types of arthritis we’re discussing. We’ve had drugs that slow rheumatoid arthritis for decades. In fact, more than a dozen FDA-approved drugs can reduce, or even halt, joint damage in people with rheumatoid arthritis. We also have effective medications to slow or stop gout, another common type of arthritis.

But the headline refers to osteoarthritis, the most common type of arthritis. And currently, no medications can safely and reliably slow the pace of this worsening joint disease. That’s one reason so many knee and hip replacements are performed: more than 1.2 million each year in the US alone.

A drug that can slow down joint degeneration in osteoarthritis has long been the holy grail of arthritis treatments, because it could

  • relieve pain and lessen suffering for millions of people
  • help prevent the loss of function that accompanies osteoarthritis
  • reduce the need for surgery, along with its attendant risks, expense, and time needed for recovery.

And, needless to say, such a drug would generate enormous profits for the pharmaceutical company that comes up with it first.

A study of heart disease might have identified a new treatment for osteoarthritis

According to new research published in Annals of Internal Medicine, it’s possible that such a treatment exists, and is already in use to treat other conditions. The researchers reanalyzed data on more than 10,000 people that originally looked at whether the drug canakinumab was beneficial for people with a previous heart attack — yes, heart attack, not arthritis.

Canakinumab inhibits interleukin-1, a substance closely involved with inflammation. And increasing evidence suggests that inflammation raises risk for cardiovascular disease, and may predict future cardiovascular trouble. All study participants had previously had a heart attack. Additionally, they had an elevated blood C-reactive protein (CRP) level, an indicator of inflammation in the body.

Every three months, each person received an injection of one of several doses of either canakinumab or a placebo. Canakinumab appeared to work for heart disease: those receiving the 150-mg dose of canakinumab had significantly fewer cardiovascular complications (repeat heart attack, stroke, or cardiovascular death) over about four years. Unfortunately, there was also a higher rate of fatal infections in the canakinumab-treated subjects.

Another look at this study of canakinumab

The reanalysis compares rates of hip or knee replacement due to osteoarthritis in those receiving canakinumab with rates among those who received a placebo. The study authors thought that since canakinumab reduces inflammation, it might help the inflammation found in the joints of people with osteoarthritis while also offering cardiovascular benefits.

Osteoarthritis has long been considered a wear-and-tear, age-related, and non-inflammatory form of joint disease. But over the last decade or so, research has demonstrated that some degree of inflammation occurs in osteoarthritis. So it’s not too much of a stretch to think a drug like canakinumab might be effective for osteoarthritis. This drug is already approved for a number of inflammatory conditions, including certain forms of pediatric arthritis.

The results of this new study surprised me: over about four years, those receiving canakinumab were at least 40% less likely to have a hip or knee replacement than those receiving placebo.

Warning: These results are preliminary

Before declaring victory over osteoarthritis with canakinumab treatment, it’s important to acknowledge that this trial doesn’t prove it actually works. That’s because the trial

  • was not a treatment trial of people with osteoarthritis. More than 80% of participants had no history of osteoarthritis.
  • did not compare x-rays or other imaging tests before and after treatment to confirm the diagnosis of osteoarthritis, or demonstrate that treatment slowed its progression
  • did not assess whether joint pain was present before treatment or improved after treatment. It’s possible that the reason there were fewer joint replacements among people taking canakinumab is that the medication reduced pain, rather than slowing joint damage. Perhaps the medication can delay the need for joint replacement by reducing symptoms without slowing progression of joint damage.
  • lasted about four years. The results could have been different if it had lasted longer.
  • only included people who had prior heart attack and an elevated CRP. The results may not apply to people who have no history of cardiovascular problems or a normal CRP.

To learn whether canakinumab actually can slow osteoarthritis, we need a proper trial that enrolls people with osteoarthritis, and compares symptoms and x-rays after treatment with canakinumab or placebo.

Canakinumab is expensive, nearly $70,000/year (though discounts, insurance coverage, and copays vary), and only available by injection. It’s not clear how many people with osteoarthritis would accept such treatment. If it is proven highly effective at preventing the need for joint replacement surgery, its high cost might be easier to accept.

The bottom line

We need definitive information about the potential of canakinumab or related drugs to treat osteoarthritis and slow its progression. Until then, it’s unlikely to become a common option.

If you have osteoarthritis of the knees or hips, talk to your doctor about your options, including maintaining a heathy weight, staying active, and taking pain relievers as needed. Some people improve with walking aids (such as a cane) or knee braces (for knee arthritis). Joint replacement surgery can be considered as a last resort.

As for new treatments that can slow the progression of osteoarthritis, we should be hopeful. But we’re not there yet.

Follow me on Twitter @RobShmerling

The post Stopping osteoarthritis: Could recent heart research provide a clue? appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3j4jTCB

Stress and the heart: Lessons from the pandemic

The effects of COVID-19 have been extensive, with more than seven million confirmed cases and more than 200,000 deaths in the US alone. COVID-19 has caused additional impacts on healthcare; for example, patients have delayed seeking care for serious symptoms over fears of exposure to COVID-19. But the consequences of COVID-19 have reached beyond healthcare alone, with daily impacts on our financial, social, and emotional well-being.

As we attempt to cope and settle into this new normal, we will learn about the long-term effects of these hardships. Doctors have already begun to study the effects of COVID-related stress and anxiety on people around the world.

Physical effects of stress

Stress can have real physical effects on the body, and it has been linked to a wide range of health issues. Stress directly activates our sympathetic nervous system, initiating a fight-or-flight response that can elevate blood pressure and blood sugar. Though potentially useful in the short term from an evolutionary standpoint, stress can worsen hypertension and diabetes when it occurs chronically. Stress can disrupt our sleep, and can lead us to make unhealthy food choices, as we seek comfort foods or abandon portion control.

A recent study suggests that stress due to the pandemic may already be affecting our heart health.

The link between stress and heart health

Stress cardiomyopathy, also called Takotsubo cardiomyopathy and broken-heart syndrome, is a cardiac disorder characterized by a sudden onset of chest pain and heart dysfunction that mimics a heart attack. But, in contrast with what is seen during a heart attack, doctors are unable to find evidence of a blood clot or abnormalities with cardiac blood flow.

Typical stress cardiomyopathy patients are postmenopausal women experiencing sudden onset of chest pain and shortness of breath. The link between stress and stress cardiomyopathy is well documented; patients with stress cardiomyopathy often experience emotional or physical stress in the week preceding their illness. The exact mechanism of this reaction is not clearly understood, but researchers have found changes in blood flow to the brain and in signaling of stress-related hormones.

Emotional triggers of stress cardiomyopathy include death of a spouse or family member, divorce or interpersonal conflict, and natural disasters such as earthquakes and floods. It stands to reason that living with the chronic stress of a global pandemic could also trigger this syndrome.

Pandemic-related stress is already affecting heart health

A recent study published in JAMA Network Open attempted to measure the effect of COVID-19-related stress on our health by looking at the prevalence of stress cardiomyopathy during the pandemic. The researchers compared the incidence of stress cardiomyopathy during the COVID-19 pandemic (March 1 to April 30, 2020) to the incidence of stress cardiomyopathy during three prior periods (in 2018, 2019, and earlier in 2020). Importantly, all patients included in the study tested negative for COVID-19.

Researchers found that there was a significant rise in stress cardiomyopathy during the COVID-19 period, with stress cardiomyopathy occurring more than four times as often as usual during March and April 2020.

Fortunately, heart function typically recovers over one to two weeks in people with stress cardiomyopathy, and prognosis is generally good. However, affected patients do have an increased risk of recurrence.

Take steps to manage stress

This study is a cautionary tale regarding the impact of stress. It serves as a good reminder that we should all strive to minimize stress, even in these trying times, and improve how we handle it. Some practical tips for managing stress including choosing healthy foods, exercising regularly, getting enough sleep, and staying connected with friends and family.

The post Stress and the heart: Lessons from the pandemic appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3nUc5a2

Fibromyalgia: Exercise helps — here’s how to start

If you have fibromyalgia and you’re in pain, exercising is probably the last thing you feel like doing. But experts say it’s actually one of the most effective strategies you can try to help manage this chronic pain condition.

Yet many people with fibromyalgia already struggle to get through their regular daily activities. Adding exercise on top of that may seem insurmountable. And pain and exhaustion can make it difficult to start and stick with regular workouts.

Getting started

It’s natural to worry that any exercise will make your pain worse and leave you wiped out. But know that adding more physical activity into your day may actually decrease your pain, improve your sleep, and give you more energy.

So, how does a worried person with fibromyalgia get started? You might want to talk with your doctor about your current medical therapy when you’re planing to begin exercising. Questions to consider: Should I take my medications at different times of the day? What can I do either before I exercise or right after to minimize symptoms?

Take it slow

When you are ready to begin an exercise program, start slowly. Taking a small-steps approach to beginning an exercise plan can help. Add activity in small doses, every day if you can. Then build up your activity slowly over time.

For example, if you walked for 10 minutes today, try 11 minutes — a 10% increase — a week later. This approach is especially important for avoiding a phenomenon called post-exertional malaise (PEM). Many people with fibromyalgia have this problem. When they feel less pain or more energy, they may try to get things done that they have been unable to do because of symptoms. Often, they don’t realize when they are doing too much at once. They may wind up feeling so exhausted that it takes days or longer to recover. This is PEM, better known to people with fibromyalgia as a “crash.” A gradual approach to exercise can help prevent it.

Choose activities carefully

In addition to gradually increasing movement over time, also try to choose activities that won’t put too much strain on your body. Experts typically recommend any low-impact aerobic activity, such as walking, swimming, or cycling. Your doctor may advise you to work with a physical therapist on exercises specifically aimed at reducing pain and stiffness and improving function. This may include stretching and strengthening as well as aerobic exercise.

Another form of exercise that has shown promise for people with fibromyalgia is tai chi. This ancient Chinese practice originated as a form of self-defense. It involves slow, deliberate movements and deep breathing exercises.

One 2018 study in The BMJ looked at 226 adults with fibromyalgia. Researchers assigned 151 members of the group to practice tai chi once or twice a week for either 12 or 24 weeks. The other 75 study participants did moderate-intensity aerobic exercise twice a week for six months. Researchers found that tai chi was better at relieving fibromyalgia symptoms than aerobic exercise.

Some limited evidence also suggests that yoga may also help to improve fibromyalgia symptoms, including pain, fatigue, and mood problems.

Whatever activity you choose, remember to be patient with yourself. Short-term setbacks may occur, but being patient and working to overcome them can help you make long-term progress.

The post Fibromyalgia: Exercise helps — here’s how to start appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3dzJa6J

Grandparenting: Navigating risk as the pandemic continues

At the end of March, as the pandemic reshaped all our lives, I wrote a blog post about how grandparents might cope with safety recommendations made at that time while remaining connected with their families. Many of us hoped that the crisis would be short-lived, enabling us to return to “normal” before too long. Now six months have elapsed, and as one reader recently wrote to me, “we grandparents are muddling through.”

So, with fall here and winter on the way, what’s next for grandparents? Those with serious medical conditions may find little has changed since March: it’s still safest to limit in-person contact with grandchildren and the outside world. For grandparents who have been able to connect outdoors with family for bike rides, meetups at a park, shared meals outside — or even vacationing together — new decisions loom as grandchildren return to preschool or school, spending more time with other kids and other families. Given what we know currently about COVID-19, how can we consider decisions about the risks and rewards of grandparenting, then navigate these with our adult children?

Do the basics

All of us benefit from taking basic preventive steps: handwashing, physical distancing, meeting outdoors when weather permits, and mask-wearing. It’s also important for everyone in the family to get a flu shot this fall. Fortunately, the same steps that help protect against COVID-19 also help protect us from the flu and other illnesses.

Balance piles of safety and piles of risk

As pediatrician Aaron Carroll wrote in an opinion piece in the New York Times, we can group our actions as piles of safety and piles of risk. Like many experts, he advises tradeoffs: if we do something that involves some risk, then we are wise to balance it with low-risk behavior. What this may mean operationally is that if you decide to see your grandchildren indoors, you may also decide to further limit shopping in stores or spending time in public. And you may ask your children to further limit their contact with friends and their own ventures out.

Keep conversations ongoing

Would that we could all have one conversation with our adult children and then be done with it. By this point in the pandemic, most grandparents have discovered that conversations around COVID-19 are ongoing. In the beginning many encountered a large dose of protectionism: their adult children were on a mission to keep them safe. Many of these protectors have since eased up, in some instances so much so that grandparents now find themselves in the position of defending caution.

Grandparents need to be clear with their adult children regarding what they see as safe and unsafe — and somewhere in between. Many find it helps to talk regularly about what everyone in the family is doing, not doing, and plans to do. For example, if the grandparents feel it is unsafe to eat in a restaurant indoors or to attend a dinner party with friends, they may elect to quarantine from the grandchildren for 14 days following the event.

Avoid judgment

One of the many challenges of the pandemic has been avoiding judgment about other people’s decisions. When it comes to having frank and productive conversations with adult children, it is especially important to avoid sounding judgmental. You may feel that your son needs to go to the dentist. By contrast, you may see his doubles tennis game as unnecessary. Part of your agreement with your adult children is that you will not judge or criticize their decisions, but you need to be free to turn down some babysitting requests (as in the doubles game) and accept others (as in the dentist). And if you find that certain choices expose you to risks that feel worrisome or unacceptable, you need to be free to share that information and to step back from gathering with them if risks outweigh benefits.

I know that everyone reading this joins me in hoping that the pandemic will be behind us in the not-too-distant future. In the meantime, all of us continue to muddle through, making the best decisions we can at a given moment in time. Staying aware of updated medical information about the virus and of its incidence where you live is key. Talking to your health care team about your personal risks and decisions can help, too. As we head into fall, many of us will visit and revisit, work and rework rules and conversations about seeing our grandchildren. I believe we will all do our best to make decisions that help ensure everyone’s health.

The post Grandparenting: Navigating risk as the pandemic continues appeared first on Harvard Health Blog.



from Harvard Health Blog https://ift.tt/3lDzKtt